457 related articles for article (PubMed ID: 31758423)
61. Hypoxia induces production of citrullinated proteins in human fibroblast-like synoviocytes through regulating HIF1α.
Yu R; Li C; Sun L; Jian L; Ma Z; Zhao J; Liu X
Scand J Immunol; 2018 Apr; 87(4):e12654. PubMed ID: 29484680
[TBL] [Abstract][Full Text] [Related]
62. Rheumatoid arthritis antigens homocitrulline and citrulline are generated by local myeloperoxidase and peptidyl arginine deiminases 2, 3 and 4 in rheumatoid nodule and synovial tissue.
Turunen S; Huhtakangas J; Nousiainen T; Valkealahti M; Melkko J; Risteli J; Lehenkari P
Arthritis Res Ther; 2016 Oct; 18(1):239. PubMed ID: 27765067
[TBL] [Abstract][Full Text] [Related]
63. Vitamin B12 inhibits peptidylarginine deiminases and ameliorates rheumatoid arthritis in CAIA mice.
Yang CW; Hsu HY; Lee YZ; Lee SJ
Biochem Biophys Res Commun; 2024 Apr; 704():149668. PubMed ID: 38401303
[TBL] [Abstract][Full Text] [Related]
64. Heightened immune response to autocitrullinated Porphyromonas gingivalis peptidylarginine deiminase: a potential mechanism for breaching immunologic tolerance in rheumatoid arthritis.
Quirke AM; Lugli EB; Wegner N; Hamilton BC; Charles P; Chowdhury M; Ytterberg AJ; Zubarev RA; Potempa J; Culshaw S; Guo Y; Fisher BA; Thiele G; Mikuls TR; Venables PJ
Ann Rheum Dis; 2014 Jan; 73(1):263-9. PubMed ID: 23463691
[TBL] [Abstract][Full Text] [Related]
65. Rheumatoid arthritis and citrullination.
Darrah E; Andrade F
Curr Opin Rheumatol; 2018 Jan; 30(1):72-78. PubMed ID: 28937414
[TBL] [Abstract][Full Text] [Related]
66. Association of Baseline Peptidylarginine Deiminase 4 Autoantibodies With Favorable Response to Treatment Escalation in Rheumatoid Arthritis.
Darrah E; Yu F; Cappelli LC; Rosen A; O'Dell JR; Mikuls TR
Arthritis Rheumatol; 2019 May; 71(5):696-702. PubMed ID: 30507066
[TBL] [Abstract][Full Text] [Related]
67. Platelets derived citrullinated proteins and microparticles are potential autoantibodies ACPA targets in RA patients.
Xu M; Du R; Xing W; Chen X; Wan J; Wang S; Xiong L; Nandakumar KS; Holmdahl R; Geng H
Front Immunol; 2023; 14():1084283. PubMed ID: 36761728
[TBL] [Abstract][Full Text] [Related]
68. Effect of iguratimod and methotrexate on RANKL and OPG expression in serum and IL-1β-induced fibroblast-like synoviocytes from patients with rheumatoid arthritis.
Wang XT; Li P; Xu TS; Ding R; Zhang X; Bi LQ
Cell Mol Biol (Noisy-le-grand); 2016 Oct; 62(12):44-50. PubMed ID: 27894399
[TBL] [Abstract][Full Text] [Related]
69. Autophagy generates citrullinated peptides in human synoviocytes: a possible trigger for anti-citrullinated peptide antibodies.
Sorice M; Iannuccelli C; Manganelli V; Capozzi A; Alessandri C; Lococo E; Garofalo T; Di Franco M; Bombardieri M; Nerviani A; Misasi R; Valesini G
Rheumatology (Oxford); 2016 Aug; 55(8):1374-85. PubMed ID: 27074807
[TBL] [Abstract][Full Text] [Related]
70. Porphyromonas gulae and PPAD antibodies are not related to citrullination in rheumatoid arthritis.
Castellar-Mendoza C; Castillo DM; Chila-Moreno L; Bautista-Molano W; Romero-Sánchez C
Clin Oral Investig; 2023 Jul; 27(7):3509-3519. PubMed ID: 37133700
[TBL] [Abstract][Full Text] [Related]
71. Autoantibodies against citrullinated histone H3 in rheumatoid arthritis and periodontitis patients.
Janssen KMJ; de Smit MJ; Withaar C; Brouwer E; van Winkelhoff AJ; Vissink A; Westra J
J Clin Periodontol; 2017 Jun; 44(6):577-584. PubMed ID: 28370244
[TBL] [Abstract][Full Text] [Related]
72. Anti-Citrullinated Protein Antibody Reactivity towards Neutrophil-Derived Antigens: Clonal Diversity and Inter-Individual Variation.
Cîrciumaru A; Afonso MG; Wähämaa H; Krishnamurthy A; Hansson M; Mathsson-Alm L; Keszei M; Stålesen R; Ottosson L; de Vries C; Shelef MA; Malmström V; Klareskog L; Catrina AI; Grönwall C; Hensvold A; Réthi B
Biomolecules; 2023 Mar; 13(4):. PubMed ID: 37189377
[TBL] [Abstract][Full Text] [Related]
73. Iguratimod Restrains Circulating Follicular Helper T Cell Function by Inhibiting Glucose Metabolism
Bai Z; Lu Z; Liu R; Tang Y; Ye X; Jin M; Wang G; Li X
Front Immunol; 2022; 13():757616. PubMed ID: 35720293
[TBL] [Abstract][Full Text] [Related]
74. The Effectiveness and Retention Rate of Iguratimod in Japanese Rheumatoid Arthritis Patients with/without Methotrexate in Daily Medical Care.
Inoue A; Nozaki Y; Hirooka Y; Kinoshita K; Chiba Y; Funauchi M; Matsumura I
Life (Basel); 2020 Oct; 10(11):. PubMed ID: 33138014
[TBL] [Abstract][Full Text] [Related]
75. Heavy Chain Constant Region Usage in Antibodies to Peptidylarginine Deiminase 4 as a Marker of Disease Subsets in Rheumatoid Arthritis.
Gómez-Bañuelos E; Shi J; Wang H; Danila MI; Bridges SL; Giles JT; Sims GP; Andrade F; Darrah E
Arthritis Rheumatol; 2022 Nov; 74(11):1746-1754. PubMed ID: 35675168
[TBL] [Abstract][Full Text] [Related]
76. Antibodies against transglutaminases, peptidylarginine deiminase and citrulline in rheumatoid arthritis--new pathways to epitope spreading.
Roth EB; Stenberg P; Book C; Sjöberg K
Clin Exp Rheumatol; 2006; 24(1):12-8. PubMed ID: 16539813
[TBL] [Abstract][Full Text] [Related]
77. Combination therapy of methotrexate and iguratimod for female patients with moderate to severe active rheumatoid arthritis and its impact on ovarian function.
Jingzhou Z; Xiong Z; Xin KQ
Pak J Pharm Sci; 2023 Sep; 36(5(Special)):1657-1662. PubMed ID: 38008964
[TBL] [Abstract][Full Text] [Related]
78. Prevalence of soluble peptidylarginine deiminase 4 (PAD4) and anti-PAD4 antibodies in autoimmune diseases.
Umeda N; Matsumoto I; Kawaguchi H; Kurashima Y; Kondo Y; Tsuboi H; Ogishima H; Suzuki T; Kagami Y; Sakyu T; Ishigami A; Maruyama N; Sumida T
Clin Rheumatol; 2016 May; 35(5):1181-8. PubMed ID: 26415740
[TBL] [Abstract][Full Text] [Related]
79. Anti-Citrullinated Protein Antibodies With Multiple Specificities Ameliorate Collagen Antibody-Induced Arthritis in a Time-Dependent Manner.
Gomez AM; Brewer RC; Moon JS; Acharya S; Kongpachith S; Wang Q; Jahanbani S; Wong HH; Lanz TV; Love ZZ; Min-Oo G; Niedziela-Majka A; Robinson WH
Arthritis Rheumatol; 2024 Feb; 76(2):181-191. PubMed ID: 37610274
[TBL] [Abstract][Full Text] [Related]
80. The Expression of Non-Coding RNAs and Their Target Molecules in Rheumatoid Arthritis: A Molecular Basis for Rheumatoid Pathogenesis and Its Potential Clinical Applications.
Tsai CY; Hsieh SC; Liu CW; Lu CH; Liao HT; Chen MH; Li KJ; Wu CH; Shen CY; Kuo YM; Yu CL
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
